- Previous Close
98.66 - Open
98.40 - Bid 98.42 x 900
- Ask 99.71 x 900
- Day's Range
98.11 - 99.39 - 52 Week Range
65.39 - 104.55 - Volume
523,320 - Avg. Volume
654,296 - Market Cap (intraday)
9.893B - Beta (5Y Monthly) 0.78
- PE Ratio (TTM)
23.10 - EPS (TTM)
4.25 - Earnings Date Feb 5, 2025 - Feb 10, 2025
- Forward Dividend & Yield 0.68 (0.69%)
- Ex-Dividend Date Jan 2, 2025
- 1y Target Est
115.67
Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions. It offers services through the Medicare program to federal government, managed care plans and private insurers, state governments, and other patients. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. The company was incorporated in 1984 and is based in Birmingham, Alabama.
www.encompasshealth.com27,481
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: EHC
View MorePerformance Overview: EHC
Trailing total returns as of 12/13/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: EHC
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: EHC
View MoreValuation Measures
Market Cap
9.89B
Enterprise Value
12.54B
Trailing P/E
23.10
Forward P/E
20.53
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.92
Price/Book (mrq)
5.05
Enterprise Value/Revenue
2.41
Enterprise Value/EBITDA
10.97
Financial Highlights
Profitability and Income Statement
Profit Margin
8.10%
Return on Assets (ttm)
8.38%
Return on Equity (ttm)
22.92%
Revenue (ttm)
5.22B
Net Income Avi to Common (ttm)
431.5M
Diluted EPS (ttm)
4.25
Balance Sheet and Cash Flow
Total Cash (mrq)
147.8M
Total Debt/Equity (mrq)
102.71%
Levered Free Cash Flow (ttm)
103.55M